An open-label pilot trial involving 10 patients shows that hepatitis C virus genotype 1–infected kidneys transplanted into HCV-negative recipients, followed by direct-acting antiviral therapy, can result in excellent allograft function with cure of HCV infection.
No takes yet. Share an insight, caveat, or question.
Goldberg et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: